Capital often arrives through funds, holding companies, trusts or nominee arrangements, so the named subscriber may tell you little about who is actually behind the money. Diligence establishes the beneficial owners, source of funds and any sanctions, PEP or adverse media exposure before commitments are accepted, when it is far easier to decline than to unwind.

Screening should cover the subscribing entity, its beneficial owners and directors, intermediaries and deal counterparties against sanctions, PEP, watchlist and adverse media data. Running this at subscription and repeating it through the life of the fund keeps the picture current as structures and control change.

Portfolio companies, their directors and their key counterparties can be held under ongoing monitoring so that sanctions designations, adverse media or ownership changes surface as they occur. That gives deal teams and compliance early visibility of reputational and financial crime issues within holdings.

Yes. All three run within a single screening workflow across individuals and entities, with configurable matching thresholds so teams assess meaningful hits rather than working through large volumes of weak name matches.

ZIGRAM connects investor screening, counterparty and portfolio risk assessment, due diligence and ongoing monitoring in one workflow supported by global risk and entity intelligence, reducing manual research at deal stage and keeping a clear record of how each risk decision was reached.